These Regulations may be cited as the Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations (Northern Ireland) 2021 and shall come into operation on 1st February 2022.

In these Regulations—

• “marketing authorisation” has the meaning given by regulation 8(1) of the Human Medicines Regulations 20122;

• “medical device” has the meaning given by regulation 2(1) of the Medical Devices Regulations 20023;

• “medicinal product” has the meaning given by regulation 2(1) of the Human Medicines Regulations 2012;

• “nicotine cartridge” means a cartridge which—

  1. a

     contains a substance which is not tobacco4 but consists of, or contains, nicotine, and

  2. b

     is intended to form part of a nicotine inhaling device;

• “nicotine inhaling device” means a device which—

  1. a

     is intended to enable nicotine to be inhaled through a mouth piece (regardless of whether the device is also intended to enable any other substance to be inhaled through a mouth piece), but

  2. b

     is not tobacco, cigarette papers or a device intended to be used for the consumption of lit tobacco;

• “nicotine inhaling product” means a nicotine inhaling device, nicotine cartridge or nicotine refill substance;

• “nicotine refill substance” means a substance which—

  1. a

     is not tobacco but consists of, or contains, nicotine, and

  2. b

     is intended to be used to refill a nicotine inhaling device;

• “parallel import licence” has the meaning given by regulation 48(2) of the Human Medicines Regulations 2012;

• “prescription only medicine” has the meaning given by regulation 8(1) of the Human Medicines Regulations 2012.